CXCR4 and posterior cortical atrophy: These studies used the clinically available CXCR4 inhibitor AMD3100 combined with RT, but the PCa was modeled in ectopic (subcutaneous) grafts, which do not reflect the stroma of primary or metastatic PCa lesions [19,20].